DMRA
Damora Therapeutics, Inc.
20.20$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.0% | 96.2% | 94.0% | 92.2% | 90.6% | 98.3% | 87.2% | 84.4% | 91.2% | 100.0% | 100.0% | 100.0% | |
| 46.1% | 56.2% | 64.9% | 83.8% | 84.2% | 82.7% | 77.7% | 74.6% | 70.8% | 98.9% | 99.5% | 99.4% | |
| 88.3% | 86.7% | 83.7% | 83.8% | 84.2% | 82.7% | 77.7% | 74.6% | 70.8% | 98.9% | 99.5% | 99.4% | |
| 2.4% | 4.5% | 5.2% | 6.3% | 5.2% | 5.1% | 6.0% | 7.2% | 9.2% | 0.3% | 0.2% | 0.2% | |
| 25.3% | 15.4% | 13.3% | 13.6% | 10.4% | 15.5% | 19.6% | 29.8% | 37.9% | 7.7% | 4.7% | 5.1% | |
| 25.1% | 15.3% | 13.3% | 13.6% | 10.4% | 7.0% | 10.1% | 19.2% | 24.4% | 7.7% | 4.4% | 5.1% | |
| 0.7% | 0.5% | 0.5% | 0.3% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | – | – | |
| 8.9% | 4.5% | 5.1% | 2.7% | 2.2% | 2.2% | 2.3% | 5.5% | 4.8% | 0.2% | 0.2% | 0.6% | |
| 74.7% | 84.6% | 86.7% | 86.4% | 89.6% | 84.5% | 80.4% | 70.2% | 62.1% | 92.3% | 95.3% | 94.9% | |
| -498.7% | -669.9% | -805.4% | -977.8% | -1,158.4% | -1,619.9% | -1,822.7% | -2,070.7% | -2,669.8% | -187.1% | -96.2% | -100.5% | |
| 2.2% | 2.8% | 3.3% | 4.0% | 4.9% | 7.5% | 8.6% | 9.7% | 12.4% | 0.6% | 6.4% | 11.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.